Vinpocetine combined with Erigeron breviscapus can effectively treat non acute cerebral infarction

2015-04-23 classification: efficacy and effect: a review of 0 people Lin Yanfeng published in the Chinese Journal of practical neurological diseases showed that vinpocetine combined with Erigeron breviscapus can effectively treat non acute cerebral infarction The article points out that the clinical effect of vinpocetine combined with Breviscapine in the treatment of non acute cerebral infarction experiment shows that vinpocetine combined with Breviscapine in the treatment of non acute cerebral infarction can effectively reduce blood viscosity, improve the symptoms of neurological deficit, and the effect is good The researchers randomly divided the non acute cerebral infarction patients admitted from June 2011 to January 2013 into two groups, the control group and the observation group with 68 cases each The control group was treated with vinpocetine and the observation group was treated with Breviscapine The differences of NIHSS score and Barthel index between the two groups before and after treatment were compared, and the changes of Hemorheology between the two groups before and after treatment were compared Results after 2 weeks and 1 month of treatment, the NIHSS score of the observation group was significantly lower than that of the control group, while the Barthel index was significantly higher than that of the control group (P < 0.05) After 2 weeks of treatment, the whole blood high shear viscosity, low shear viscosity, plasma specific viscosity and erythrocyte sedimentation rate in the observation group were significantly lower than those in the control group (P < 0.05) The conclusion is that vinpocetine combined with Erigeron breviscapus can effectively reduce blood viscosity and improve the symptoms of neurological deficit in patients with non acute cerebral infarction.